Marshall Wace, LLP Inari Medical, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Inari Medical, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 41,359 shares of NARI stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,359
Previous 284,609
85.47%
Holding current value
$2.13 Million
Previous $13.7 Million
87.56%
% of portfolio
0.0%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding NARI
# of Institutions
262Shares Held
56.5MCall Options Held
90.4KPut Options Held
27.3K-
Black Rock Inc. New York, NY8.36MShares$431 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$289 Million0.0% of portfolio
-
Hcc Manager LLC Chicago, IL2.91MShares$150 Million91.04% of portfolio
-
Alliancebernstein L.P. New York, NY2.15MShares$111 Million0.03% of portfolio
-
State Street Corp Boston, MA2.04MShares$105 Million0.0% of portfolio
About Inari Medical, Inc.
- Ticker NARI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,389,700
- Market Cap $2.75B
- Description
- Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...